Sequel.Care

Company Overview

Snapshot

Founded in March 2020 by Amir Nathan, Sequel.Care operates with 11–50 employees. The company has raised $2.85M across four funding rounds from two investors. In October 2024, Sequel.Care secured a grant from the Office of the Chief Scientist.

Business overview

Sequel.Care develops digital therapeutics for mental healthcare, empowering clinicians with data-driven decision-making and therapy tools. The company's core technology focuses on personalizing treatment, identifying relapse, and facilitating therapeutic and digital interventions throughout the patient journey. Sequel.Care serves healthcare providers, insurance companies, and pharmaceutical companies, operating within the digital healthcare sector with a focus on mental health and digital therapeutics in markets including North America, the United States, and Israel.

Company Intelligence Q&A

What is Sequel.Care's primary focus?

Sequel.Care focuses on empowering clinicians with data-driven decision-making and therapy tools to optimize mental health treatment, engage patients and enhance collaboration for superior clinical outcomes.

When was Sequel.Care founded?

Sequel.Care was founded in March 2020 by Amir Nathan.

What was a recent funding event for Sequel.Care?

In October 2024, Sequel.Care secured a grant from the Office of the Chief Scientist.

What type of care does Sequel.Care emphasize?

Sequel.Care emphasizes superior integrated care through an integrative and holistic approach, providing data analysis from multiple angles and adjusting its system to the unique requirements of multidisciplinary care teams.